NeuBase Therapeutics, Inc.
NBSEDelisted May 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173281
NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in NeuBase Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NBSE is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 2
- −16 vs. Q1 2024
- Shares held
- 16.1K
- −377.3K (−95.9%) vs. Q1 2024
- Total value
- $4.95K
- −$172.1K (−97.2%) vs. Q1 2024
- New holders
- 1
- 0 more added
- Sold out
- 17
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBSE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $4.95K |
| Q1 2024 | 18 | $177.1K |
| Q4 2023 | 21 | $340.2K |
| Q3 2023 | 20 | $301.2K |
| Q2 2023 | 26 | $1.08M |
| Q1 2023 | 36 | $1.72M |
| Q4 2022 | 35 | $1.94M |
| Q3 2022 | 44 | $4.74M |
| Q2 2022 | 43 | $13.4M |
| Q1 2022 | 45 | $23.3M |
| Q4 2021 | 46 | $31.6M |
| Q3 2021 | 48 | $36.6M |
| Q2 2021 | 59 | $51.5M |
| Q1 2021 | 57 | $59.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding NeuBase Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baader Bank INC | 16,089 | $4.95K | 0.00% | +16,089 | New |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | −21−95.5% | Reduced |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 0 | $0 | 0.00% | −136,350−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −88,229−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −62,500−100.0% | Sold out |
| Carnegie Mellon University | 0 | $0 | 0.00% | −46,970−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −18,981−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −15,550−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −15,482−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,056−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,572−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,251−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −804−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −153−100.0% | Sold out |